Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells.
Nat Biotechnol. 2006 Nov; 24(11):1392-401
Julia Greenstein
20 Jul 2012
|
New Finding, Review / Commentary
This study of pancreatic lineage differentiation protocols for developing surrogate insulin-producing cells to treat diabetes demonstrated the importance of the starting cell line for successful differentiation. It demonstrated that the Viacyte protocol is most effective with the Cyt203 line.
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.